1. Home
  2. ARWR vs CHCO Comparison

ARWR vs CHCO Comparison

Compare ARWR & CHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • CHCO
  • Stock Information
  • Founded
  • ARWR 2003
  • CHCO 1957
  • Country
  • ARWR United States
  • CHCO United States
  • Employees
  • ARWR N/A
  • CHCO N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • CHCO Major Banks
  • Sector
  • ARWR Health Care
  • CHCO Finance
  • Exchange
  • ARWR Nasdaq
  • CHCO Nasdaq
  • Market Cap
  • ARWR 1.8B
  • CHCO 1.7B
  • IPO Year
  • ARWR 1993
  • CHCO N/A
  • Fundamental
  • Price
  • ARWR $18.31
  • CHCO $125.30
  • Analyst Decision
  • ARWR Buy
  • CHCO Hold
  • Analyst Count
  • ARWR 8
  • CHCO 2
  • Target Price
  • ARWR $43.71
  • CHCO $127.50
  • AVG Volume (30 Days)
  • ARWR 1.6M
  • CHCO 141.9K
  • Earning Date
  • ARWR 08-07-2025
  • CHCO 07-22-2025
  • Dividend Yield
  • ARWR N/A
  • CHCO 2.53%
  • EPS Growth
  • ARWR N/A
  • CHCO 0.39
  • EPS
  • ARWR N/A
  • CHCO 7.98
  • Revenue
  • ARWR $545,209,000.00
  • CHCO $293,748,000.00
  • Revenue This Year
  • ARWR $21,924.50
  • CHCO $6.69
  • Revenue Next Year
  • ARWR N/A
  • CHCO $1.78
  • P/E Ratio
  • ARWR N/A
  • CHCO $15.66
  • Revenue Growth
  • ARWR 1436.97
  • CHCO 1.31
  • 52 Week Low
  • ARWR $9.57
  • CHCO $102.22
  • 52 Week High
  • ARWR $30.41
  • CHCO $137.28
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 66.51
  • CHCO 58.24
  • Support Level
  • ARWR $16.45
  • CHCO $124.85
  • Resistance Level
  • ARWR $19.24
  • CHCO $129.93
  • Average True Range (ATR)
  • ARWR 0.79
  • CHCO 2.77
  • MACD
  • ARWR 0.25
  • CHCO 0.29
  • Stochastic Oscillator
  • ARWR 77.43
  • CHCO 62.56

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

About CHCO City Holding Company

City Holding Co is a financial holding company. The company conducts its principal activities through its wholly-owned subsidiary, City National Bank of West Virginia (City National). Through the bank, it provides banking, trust and investment management, and other financial solutions through its network of banking offices located in the states of West Virginia, Virginia, southeastern Ohio, and Kentucky. It offers various products and services such as overdraft facilities, savings accounts, credit cards and debit cards, loans for various purposes, investment advisory, securities brokerage, insurance products, and others. The company's business activities are currently limited to one reportable business segment, which is community banking.

Share on Social Networks: